HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.
Digital Ally Q3 EPS $(0.04) Down From $0.16 YoY, Sales $8.48M Up From $4.64M YoY
Digital Ally (NASDAQ:DGLY) reported quarterly losses of $(0.04) per share. This is a 125 percent decrease over earnings of $0.16 per share from the same period last year. The company reported $8.48 million in sales this